Synapse - Brian Shaffer

Results (175)

Letermovir for prevention of recurrent cytomegalovirus in high-risk allogeneic hematopoietic cell transplantation recipients

Journal Article

Han, G.; Stern, A.; Lee, Y. J.; Li, Y.; Dahi, P. B.; Tamari, R.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Shaffer, B.; more...
Transplantation and Cellular Therapy (2025)

Fulltext@MSK | Save

Reply to: Disparities in allograft access in the era of post-transplant cyclophosphamide-based mismatched unrelated donor transplantation

Correspondence

Shaffer, B. C.; Gooptu, M.; DeFor, T.; Spellman, S. R.; Stefanski, H. E.; Shaw, B. E.; Auletta, J. J.; Devine, S. M.; Jimenez, A. M.; Al Malki, M. M.
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

OPTIMIZE: A phase II study of reduced dose post transplantation cyclophosphamide as GVHD prophylaxis in adult patients with hematologic malignancies receiving HLA-mismatched unrelated donor peripheral blood stem cell transplantation

Meeting Abstract

Auletta, J. J.; Devine, S. M.; Stefanski, H. E.; Spellman, S. R.; Defor, T. E.; Logan, B. R.; Butler, B. J.; Gooptu, M.; Shaffer, B. C.; Jimenez, A. M. J.; more...
Blood (2024)

Fulltext@MSK | Save

CD371-targeted CAR T-cells secreting interleukin-18 exhibit robust expansion and disease clearance in patients with refractory acute myeloid leukemia

Meeting Abstract

Geyer, M. B.; Dewolf, S.; Mi, X.; Shaffer, B. C.; Cadzin, B.; McAvoy, D.; Hosszu, K. K.; Weis, K.; Lorenc, R.; Lewis, A. M.; more...
Blood (2024)

Fulltext@MSK | Save

Superiority of post-transplant cyclophosphamide-based graft versus host disease (GvHD) prophylaxis in patients 70 years and older: A BMT CTN 1703 post-hoc analysis

Meeting Abstract

Abedin, S.; Lian, Q. H.; Martens, M. J.; Malki, M. M. A.; Elmariah, H.; Gooptu, M.; Larkin, K. T.; Shaffer, B. C.; Loren, A. W.; Solh, M. M.; more...
Blood (2024)

Fulltext@MSK | Save

Long-term follow up of a prospective pilot study of an α/β T-lymphocyte depleted graft conditioned with a reduced intensity regimen in patients with hematologic malignancies

Meeting Abstract

Hughes, C. F. M.; Lin, R. J.; Devlin, S. M.; Shaffer, B. C.; Jakubowski, A. A.; Talla, V.; Saldia, A.; Gyurkocza, B.; Papadopoulos, E. B.; Giralt, S. A.; more...
Blood (2024)

Fulltext@MSK | Save

Efficacy of budesonide monotherapy for low grade GI GVHD after post transplant cyclophosphamide

Meeting Abstract

Cook, M.; Vadakkel, G.; Chinapen, S.; Perales, M. A.; Tamari, R.; Papadopoulos, E. B.; Ponce, D. M.; Shaffer, B. C.; Lin, A.
Blood (2024)

Fulltext@MSK | Save

Post-transplantation cyclophosphamide improves graft-versus-host disease-free, relapse-free survival in HLA-DPB1 mismatched unrelated donor allogeneic transplant

Meeting Abstract

McCurdy, S. R.; Solomon, S. R.; Shaffer, B. C.; He, M.; Bolon, Y. T.; Blouin, A. G.; Keyzner, A.; Socola, F. A.; Ibrahim, U.; Zou, J.; more...
Bone Marrow Transplantation (2024)

Fulltext@MSK | Save

Young matched unrelated donors should be prioritized over older-aged matched sibling donors and young haploidentical donors in allogeneic transplantation with post-transplant cyclophosphamide in recipients ≥ 50-years

Meeting Abstract

Nath, K.; Zhang, M. J.; Bye, M.; Lee, S.; Bolon, Y. T.; Benjamin, C.; Betts, B.; Gadalla, S.; Marsh, S. G. E.; Mehta, P.; more...
Bone Marrow Transplantation (2024)

Fulltext@MSK | Save

Superior disease control with younger matched unrelated donor vs older-aged matched sibling donor in recipients ≥ 50-years with ALL, AML, or MDS using CNI-based GVHD prophylaxis

Meeting Abstract

Nath, K.; Zhang, M. J.; Bye, M.; Lee, S.; Bolon, Y. T.; Benjamin, C.; Betts, B.; Gadalla, S.; Marsh, S. G. E.; Mehta, P.; more...
Bone Marrow Transplantation (2024)

Fulltext@MSK | Save

Brian Carl Shaffer

Results (175)

Journal Article

Correspondence

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract